Lesionectomy for cerebral sparganosis and concomitant epilepsy: A case series of 15 patients.
Cerebral sparganosis
Epilepsy
Lesionectomy
Seizure outcomes
Journal
Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
28
06
2021
revised:
12
08
2021
accepted:
22
08
2021
pubmed:
30
8
2021
medline:
30
3
2022
entrez:
29
8
2021
Statut:
ppublish
Résumé
To report the clinical characteristics and surgical outcomes of patients with cerebral sparganosis and concomitant epilepsy. We retrospectively collected the clinical data of all patients with cerebral sparganosis and concomitant epilepsy who underwent lesionectomy as treatment at Xiangya Hospital, Central South University between January 2015 and August 2019. Seizure outcomes were evaluated according to the International League Against Epilepsy (ILAE) classification. ILAE classes 1 and 2 were defined as favorable seizure outcomes, whereas ILAE classes 3-6 were defined as unfavorable seizure outcomes. Fifteen patients with cerebral sparganosis and concomitant epilepsy who underwent lesionectomy as treatment met the inclusion criteria. Live worms were surgical removed in 80 % of patients. With a mean follow-up of 2.4 ± 1.1 years, 66.7 % of patients demonstrated favorable seizure outcomes, with improvement of symptoms other than seizures. Longer seizure duration associated with unfavorable seizure outcomes. Lesionectomy is an effective treatment for patients with cerebral sparganosis and concomitant epilepsy. Early surgical treatment may offer more benefits to such patients.
Identifiants
pubmed: 34455177
pii: S0920-1211(21)00200-X
doi: 10.1016/j.eplepsyres.2021.106747
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106747Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.